insights_auto
Why is 600276 up 2,44%?
Dive Deeperchevron_right
600276:SHA
Jiangsu Hengrui Pharmaceuticals Co Ltd
CNÂ¥46,60
arrow_upward
+2,44%(+1,11) 1D
15 Okt., 15:00:01 GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600276...
Open
CNÂ¥44,99
High
CNÂ¥46,60
Low
CNÂ¥44,89
Mkt. cap
290,31Â mjd
Avg. vol.
60,30Â m
Volume
63,92Â m
Dividend
0,43%
Quarterly dividend
CNÂ¥0,05
Ex-dividend date
27 Mei 2026
P/E ratio
39,99
52-wk high
CNÂ¥68,50
52-wk low
CNÂ¥41,89
EPS
CNÂ¥1,17
Shares outstanding
3,68Â mjd
No. of employees
21Â k
Open
CNÂ¥44,99
High
CNÂ¥46,60
Low
CNÂ¥44,89
Mkt. cap
290,31Â mjd
Avg. vol.
60,30Â m
Volume
63,92Â m
Dividend
0,43%
Quarterly dividend
CNÂ¥0,05
Ex-dividend date
27 Mei 2026
P/E ratio
39,99
52-wk high
CNÂ¥68,50
52-wk low
CNÂ¥41,89
EPS
CNÂ¥1,17
Shares outstanding
3,68Â mjd
No. of employees
21Â k
Related stocks
News stories
From web sources and news partners
TipRanks
·
1 dag gelede
Jiangsu Hengrui sets board meeting to approve nine‑month results
ad-hoc-news.de
·
1 dag gelede
Hengrui Medicine wins EMA acceptance for Hengrui Medicine stock
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd